149 related articles for article (PubMed ID: 29440170)
1. RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma.
Houles T; Gravel SP; Lavoie G; Shin S; Savall M; Méant A; Grondin B; Gaboury L; Yoon SO; St-Pierre J; Roux PP
Cancer Res; 2018 May; 78(9):2191-2204. PubMed ID: 29440170
[TBL] [Abstract][Full Text] [Related]
2. BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS
McGrail K; Granado-Martínez P; Esteve-Puig R; García-Ortega S; Ding Y; Sánchez-Redondo S; Ferrer B; Hernandez-Losa J; Canals F; Manzano A; Navarro-Sabaté A; Bartrons R; Yanes O; Pérez-Alea M; Muñoz-Couselo E; Garcia-Patos V; Recio JA
Nat Commun; 2022 Nov; 13(1):7113. PubMed ID: 36402789
[TBL] [Abstract][Full Text] [Related]
3. RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth.
Romeo Y; Moreau J; Zindy PJ; Saba-El-Leil M; Lavoie G; Dandachi F; Baptissart M; Borden KLB; Meloche S; Roux PP
Oncogene; 2013 Jun; 32(24):2917-2926. PubMed ID: 22797077
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.
Kosnopfel C; Wendlinger S; Niessner H; Siewert J; Sinnberg T; Hofmann A; Wohlfarth J; Schrama D; Berthold M; Siedel C; Sauer B; Jayanthan A; Lenz G; Dunn SE; Schilling B; Schittek B
J Exp Clin Cancer Res; 2023 Jul; 42(1):175. PubMed ID: 37464364
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.
Méant A; Gao B; Lavoie G; Nourreddine S; Jung F; Aubert L; Tcherkezian J; Gingras AC; Roux PP
Mol Cell Proteomics; 2020 Jan; 19(1):50-64. PubMed ID: 31678930
[TBL] [Abstract][Full Text] [Related]
6. Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids.
Novellasdemunt L; Tato I; Navarro-Sabate A; Ruiz-Meana M; Méndez-Lucas A; Perales JC; Garcia-Dorado D; Ventura F; Bartrons R; Rosa JL
J Biol Chem; 2013 Apr; 288(15):10640-51. PubMed ID: 23457334
[TBL] [Abstract][Full Text] [Related]
7. RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.
Ray-David H; Romeo Y; Lavoie G; Déléris P; Tcherkezian J; Galan JA; Roux PP
Oncogene; 2013 Sep; 32(38):4480-9. PubMed ID: 23108403
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase.
Kosnopfel C; Sinnberg T; Sauer B; Niessner H; Schmitt A; Makino E; Forschner A; Hailfinger S; Garbe C; Schittek B
Oncotarget; 2017 May; 8(22):35761-35775. PubMed ID: 28415756
[TBL] [Abstract][Full Text] [Related]
9. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells.
Ozcan SC; Sarioglu A; Altunok TH; Akkoc A; Guzel S; Guler S; Imbert-Fernandez Y; Muchut RJ; Iglesias AA; Gurpinar Y; Clem AL; Chesney JA; Yalcin A
Mol Cell Biochem; 2020 Jul; 470(1-2):115-129. PubMed ID: 32415418
[TBL] [Abstract][Full Text] [Related]
10. Molecular drivers of cellular metabolic reprogramming in melanoma.
Abildgaard C; Guldberg P
Trends Mol Med; 2015 Mar; 21(3):164-71. PubMed ID: 25618774
[TBL] [Abstract][Full Text] [Related]
11. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
12. Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition.
Hardeman KN; Peng C; Paudel BB; Meyer CT; Luong T; Tyson DR; Young JD; Quaranta V; Fessel JP
Sci Rep; 2017 Feb; 7():42604. PubMed ID: 28205616
[TBL] [Abstract][Full Text] [Related]
13. Exercise-Induced Changes in Glucose Metabolism Promote Physiological Cardiac Growth.
Gibb AA; Epstein PN; Uchida S; Zheng Y; McNally LA; Obal D; Katragadda K; Trainor P; Conklin DJ; Brittian KR; Tseng MT; Wang J; Jones SP; Bhatnagar A; Hill BG
Circulation; 2017 Nov; 136(22):2144-2157. PubMed ID: 28860122
[TBL] [Abstract][Full Text] [Related]
14. Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK.
Hartman KG; Vitolo MI; Pierce AD; Fox JM; Shapiro P; Martin SS; Wilder PT; Weber DJ
J Biol Chem; 2014 May; 289(18):12886-95. PubMed ID: 24627490
[TBL] [Abstract][Full Text] [Related]
15. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.
Moon JS; Jin WJ; Kwak JH; Kim HJ; Yun MJ; Kim JW; Park SW; Kim KS
Biochem J; 2011 Jan; 433(1):225-33. PubMed ID: 20958264
[TBL] [Abstract][Full Text] [Related]
16. A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells.
Arden C; Hampson LJ; Huang GC; Shaw JA; Aldibbiat A; Holliman G; Manas D; Khan S; Lange AJ; Agius L
Biochem J; 2008 Apr; 411(1):41-51. PubMed ID: 18039179
[TBL] [Abstract][Full Text] [Related]
17. mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation.
Chou PC; Rajput S; Zhao X; Patel C; Albaciete D; Oh WJ; Daguplo HQ; Patel N; Su B; Werlen G; Jacinto E
Cells; 2020 Jun; 9(7):. PubMed ID: 32605013
[TBL] [Abstract][Full Text] [Related]
18. Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma.
Smith LK; Rao AD; McArthur GA
Pharmacol Res; 2016 May; 107():42-47. PubMed ID: 26924126
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
20. Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors.
Marchetti P; Trinh A; Khamari R; Kluza J
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):999-1005. PubMed ID: 29413908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
